M.W. Lucas

Statistics

Publications

Citations

135

H-Index

Active since

2023

Affiliations

The Netherlands Cancer Institute(Current)

Oncode Institute

M.W. Lucas is an author at The Netherlands Cancer Institute specializing in oncology, cytotoxic t-lymphocyte antigen 4 (ctla-4) pathway, and immunotherapy.

Publications per year

2023–2024

Publications

Combination anti-PD-1 and anti-CTLA-4 therapy generates waves of clonal responses that include progenitor-exhausted CD8+ T cells

Kevin Wang, Paulina Coutifaris, David Brocks et al. · Cancer Cell · 2024 · 96 citations · Full text

Life Sciences, Immunology, Oncology +16

Primary adrenal insufficiency induced by immune checkpoint inhibitors: biological, clinical, and radiological aspects

Serafina Martella, M.W. Lucas, Michele Porcu et al. · Seminars in Oncology · 2023 · 27 citations · Full text

Pharmacy, Endocrinology, Oncology +17

LBA42 Distant metastasis-free survival of neoadjuvant nivolumab plus ipilimumab versus adjuvant nivolumab in resectable, macroscopic stage III melanoma: The NADINA trial

M.W. Lucas, A.M. Menzies, Marta López‐Yurda et al. · Annals of Oncology · 2024 · 12 citations · Full text

Medicine, Oncology, Pharmacology +17

1–3 of 3